MYnd Analytics: Surges on merger agreement with Emmaus Life Sciences

Emmaus Life Sciences

07/01/2019 14:14

** Healthcare services company's shares  MYND.O  up 56 pct
at $1.17 premarket 
    ** MYND and privately held Emmaus Life Sciences say they
will merge into a combined company  urn:newsml:reuters.com:*:nGNX7q65FK
    ** Emmaus will become a wholly owned unit of MYnd Analytics,
in exchange for MYnd Analytics' issuance of common stock to
Emmaus shareholders
    ** MYND says stock issuance will result in Emmaus
security-holders owning about 94 pct of MYnd's common stock
after the merger
    ** Surviving company will change its name to Emmaus and have
a new ticker symbol 
    ** Stock had fallen 77.6 pct in the past 12 months

 (Reporting by Manas Mishra in Bengaluru)
 ((Reuters Messaging:
manas.mishra.thomsonreuters.com@reuters.net))